Annual report
4502.TEDINET S100TNTP
Period2023-04-01 → 2024-03-31
Filed2024-06-26
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.26T | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥4.03T | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥3.57T | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.20T | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.29T | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥214.1bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥490.5bn | 2022-04-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥52.8bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥375.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥302.6bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥366.2bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥60.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥144.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥317.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥230.1bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥376.0bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥44.2bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥144.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥317.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥230.2bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥376.2bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥44.3bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥15.11T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥13.96T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥13.18T | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥12.91T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥12.82T | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥7.83T | at 2024-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥7.60T | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥7.27T | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥6.35T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥5.68T | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥7.27T | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥6.35T | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥457.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥533.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥849.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥966.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥637.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥716.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥977.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥1.12T | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.01T | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥669.8bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥463.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥607.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥198.1bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥393.5bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥292.1bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥354.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥709.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥1.07T | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.09T | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.01T | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥92.09 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥204.29 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥147.14 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥240.72 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥28.41 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥91.16 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥201.94 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥145.87 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥238.96 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥28.25 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥4,635.56 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥4,087.49 | at 2023-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,665.61 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,308.93 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥3,032.22 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 48.1% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.5% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 43.1% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.1% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 36.8% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 2.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 5.3% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 4.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 0.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 49,281 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 49,095 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 47,347 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 47,099 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 47,495 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥595.6bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥632.1bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥764.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥602.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥616.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥48.1bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥136.1bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥286.4bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥340.1bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥550.9bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥50.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥72.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥391.3bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥383.0bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥338.9bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥330.6bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥324.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥247.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥130.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.76T | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥9.41T | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥9.64T | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥10.86T | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥10.29T | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.67T | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.20T | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.09T | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.21T | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.29T | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥4.43T | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.55T | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥130.9bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥164.9bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥216.6 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.06 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.5 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.45 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.88 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥216.56 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥213.05 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥207.5 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥158.44 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.87 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥188 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,604.87 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,704.87 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,769.31 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,835.81 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,919.21 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 41.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.2% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,582,419,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,296,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,582,253,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,576,388,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,576,374,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 5,474 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 5,486 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 5,149 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 4,966 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 5,350 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2024-03-31 | 49281 pure |
| Pharmaceutical Businessreportable segment | employees | at 2024-03-31 | 5474 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,742
| Item | Context | Value | Unit |
|---|---|---|---|
| Total transactions with owners IFRS | CurrentYearDuration_NonControllingInterestsIFRSMember | 18000000 | JPY |
| Total transactions with owners IFRS | CurrentYearDuration | -219873000000 | JPY |
| Equity IFRS | CurrentYearInstant_EffectivePortionOfCashFlowHedgesIFRSMember | -63896000000 | JPY |
| Equity IFRS | CurrentYearInstant_jpcrp030000-asr_E00919-000HedgeCostIFRSMember | -15930000000 | JPY |
| Equity IFRS | CurrentYearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember | － | JPY |
| Equity IFRS | CurrentYearInstant_OtherComponentsOfEquityIFRSMember | 2509310000000 | JPY |
| Equity IFRS | CurrentYearInstant_EquityAttributableToOwnersOfParentIFRSMember | 7273264000000 | JPY |
| Equity IFRS | CurrentYearInstant_NonControllingInterestsIFRSMember | 741000000 | JPY |
| Equity IFRS | CurrentYearInstant | 7274005000000 | JPY |
| Profit loss IFRS | Prior1YearDuration | 317038000000 | JPY |
| Profit loss IFRS | CurrentYearDuration | 144197000000 | JPY |
| Depreciation and amortization ope cf IFRS | Prior1YearDuration | 664400000000 | JPY |
| Depreciation and amortization ope cf IFRS | CurrentYearDuration | 728002000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | Prior1YearDuration | 64394000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | CurrentYearDuration | 150017000000 | JPY |
| Share based payment expenses ope cf IFRS | Prior1YearDuration | 60672000000 | JPY |
| Share based payment expenses ope cf IFRS | CurrentYearDuration | 70871000000 | JPY |
| Loss gain on disposal and sale of property plant and equipment ope cf IFRS | Prior1YearDuration | 10000000 | JPY |
| Loss gain on disposal and sale of property plant and equipment ope cf IFRS | CurrentYearDuration | 6052000000 | JPY |
| Gain on sale of businesses ope cf IFRS | Prior1YearDuration | -6807000000 | JPY |
| Gain on sale of businesses ope cf IFRS | CurrentYearDuration | -7832000000 | JPY |
| Change in fair value of financial assets and liabilities associated with contingent consideration arrangements net ope cf IFRS | Prior1YearDuration | 3991000000 | JPY |
| Change in fair value of financial assets and liabilities associated with contingent consideration arrangements net ope cf IFRS | CurrentYearDuration | 20757000000 | JPY |
| Finance income and finance costs ope cf IFRS | Prior1YearDuration | 106785000000 | JPY |
| Finance income and finance costs ope cf IFRS | CurrentYearDuration | 167757000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | Prior1YearDuration | 8630000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | CurrentYearDuration | -6473000000 | JPY |
| Income tax expense ope cf IFRS | Prior1YearDuration | 58052000000 | JPY |
| Income tax expense ope cf IFRS | CurrentYearDuration | -91406000000 | JPY |
| Decrease increase in trade and other receivables2 ope cf IFRS | Prior1YearDuration | 75127000000 | JPY |
| Decrease increase in trade and other receivables2 ope cf IFRS | CurrentYearDuration | 15104000000 | JPY |
| Decrease increase in inventories ope cf IFRS | Prior1YearDuration | -79155000000 | JPY |
| Decrease increase in inventories ope cf IFRS | CurrentYearDuration | -115743000000 | JPY |
| Increase decrease in trade and other payables2 ope cf IFRS | Prior1YearDuration | -84804000000 | JPY |
| Increase decrease in trade and other payables2 ope cf IFRS | CurrentYearDuration | -9895000000 | JPY |
| Increase decrease in provisions ope cf IFRS | Prior1YearDuration | 31899000000 | JPY |
| Increase decrease in provisions ope cf IFRS | CurrentYearDuration | -126901000000 | JPY |
| Increase decrease in other financial liabilities ope cf IFRS | Prior1YearDuration | 31669000000 | JPY |
| Increase decrease in other financial liabilities ope cf IFRS | CurrentYearDuration | -18568000000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1YearDuration | -88778000000 | JPY |
| Other changes in working capital ope cf IFRS | CurrentYearDuration | -7556000000 | JPY |
| Cash generated from operations ope cf IFRS | Prior1YearDuration | 1163122000000 | JPY |
| Cash generated from operations ope cf IFRS | CurrentYearDuration | 918383000000 | JPY |
| Income taxes paid ope cf IFRS | Prior1YearDuration | -198439000000 | JPY |
| Income taxes paid ope cf IFRS | CurrentYearDuration | -219941000000 | JPY |
| Tax refunds and interest on tax refunds received ope cf IFRS | Prior1YearDuration | 12473000000 | JPY |
| Tax refunds and interest on tax refunds received ope cf IFRS | CurrentYearDuration | 17902000000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1YearDuration | 977156000000 | JPY |
| Net cash provided by used in operating activities IFRS | CurrentYearDuration | 716344000000 | JPY |
| Interest received inv cf IFRS | Prior1YearDuration | 5054000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |